These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17999929)

  • 1. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
    J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic binding to dizinc beta-lactamase L1 from Stenotrophomonas maltophilia: SCC-DFTB/CHARMM and DFT studies.
    Xu D; Guo H; Cui Q
    J Phys Chem A; 2007 Jul; 111(26):5630-6. PubMed ID: 17388313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H
    Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases.
    Simm AM; Loveridge EJ; Crosby J; Avison MB; Walsh TR; Bennett PM
    Biochem J; 2005 May; 387(Pt 3):585-90. PubMed ID: 15569001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of D- and L-captopril inhibitors to metallo-beta-lactamase studied by polarizable molecular mechanics and quantum mechanics.
    Antony J; Gresh N; Olsen L; Hemmingsen L; Schofield CJ; Bauer R
    J Comput Chem; 2002 Oct; 23(13):1281-96. PubMed ID: 12210153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
    Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
    Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display.
    Sanschagrin F; Levesque RC
    J Antimicrob Chemother; 2005 Feb; 55(2):252-5. PubMed ID: 15659541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution.
    Ullah JH; Walsh TR; Taylor IA; Emery DC; Verma CS; Gamblin SJ; Spencer J
    J Mol Biol; 1998 Nov; 284(1):125-36. PubMed ID: 9811546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the role of Asp-120 in metallo-beta-lactamases.
    Crisp J; Conners R; Garrity JD; Carenbauer AL; Crowder MW; Spencer J
    Biochemistry; 2007 Sep; 46(37):10664-74. PubMed ID: 17715946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T; Bethel CR; Bonomo RA; Knox JR
    Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
    Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R
    J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
    Wang X; Minasov G; Shoichet BK
    Proteins; 2002 Apr; 47(1):86-96. PubMed ID: 11870868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
    Roth TA; Minasov G; Morandi S; Prati F; Shoichet BK
    Biochemistry; 2003 Dec; 42(49):14483-91. PubMed ID: 14661960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic deactivation by a dizinc beta-lactamase: mechanistic insights from QM/MM and DFT studies.
    Xu D; Guo H; Cui Q
    J Am Chem Soc; 2007 Sep; 129(35):10814-22. PubMed ID: 17691780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Force field design and molecular dynamics simulations of the carbapenem- and cephamycin-resistant dinuclear zinc metallo-beta-lactamase from Bacteroides fragilis and its complex with a biphenyl tetrazole inhibitor.
    Park H; Merz KM
    J Med Chem; 2005 Mar; 48(5):1630-7. PubMed ID: 15743204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
    Pernot L; Frénois F; Rybkine T; L'Hermite G; Petrella S; Delettré J; Jarlier V; Collatz E; Sougakoff W
    J Mol Biol; 2001 Jul; 310(4):859-74. PubMed ID: 11453693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole.
    Rigden DJ; Botzki A; Nukui M; Mewbourne RB; Lamani E; Braun S; von Angerer E; Bernhardt G; Dove S; Buschauer A; Jedrzejas MJ
    Glycobiology; 2006 Aug; 16(8):757-65. PubMed ID: 16638841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
    J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases.
    Johnson JW; Gretes M; Goodfellow VJ; Marrone L; Heynen ML; Strynadka NC; Dmitrienko GI
    J Am Chem Soc; 2010 Mar; 132(8):2558-60. PubMed ID: 20141132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis.
    Park H; Brothers EN; Merz KM
    J Am Chem Soc; 2005 Mar; 127(12):4232-41. PubMed ID: 15783205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.